ArticleOncology letters2026
Pomegranate peel-derived exosome-like nanoparticles: A discarded treasure trove for colorectal cancer treatment.
Article in Oncology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colorectal cancer (CRC) is the leading cause of cancer-related deaths. Thus, there is an urgent need for effective treatment strategies. Exosomes and exosome-like nanoparticles (ELNs) have recently received widespread attention due to their various bioactivity functions and potential clinical applications. The present study focused on the molecular mechanism of pomegranate peel-derived ELNs (PELNs) in anti-CRC therapy. PELNs were successfully extracted via the ultra-centrifugation method and were effectively received by CRC cells (SW480). In addition, the proliferation and migration of CRC cells treated with PELNs were significantly inhibited
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.